Peritoneal carcinomatosis treatment with curative intent: The Institut Gustave-Roussy experience

European Journal of Surgical Oncology

Volumn 23, Issue 4, 1997, Pages 317-321

  Elias, D ^a   Dube P ^a   Blot, F ^a   Bonvallot, S ^a   Eggenspieler, P ^a   Sabourin, J C ^a   Ducreux, M ^a   Rougier, Ph ^a   Lasser, Ph ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cytoreductive surgery; Intraperitoneal chemotherapy; Peritoneal carcinomatosis

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; FEMALE; HEALTH CARE COST; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MORBIDITY; OPERATION DURATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SURGICAL MORTALITY;

EID: 0030768619     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(97)90750-2     Document Type: Article

References (23)

1. Markman M, Reichman B, Hakes T. et al. Intraperioneal chemotherapy in the management of ovarian cancer. Cancer 1993; 71: 1565-70.
2. Chu DZ, Lang NP, Thompson C. Osteen PK. Westbrook K.C. Peritoneal carcinomatosis in non-gynecologic malignancy. Cancer 1989; 63; 364-7.
3. Elias D. La chirurgie de cytoréduction tumorale: mythe ou réalité? J Chir 1992; 129: 479-83.
4. Kemeny et al. Current approaches to metastatic colorectal cancer. Semin Oncol 1994; 21: 67-75.
5. Richardson GS, Scully GS, Nikrui N, Nelson JH. Common epithelial cancer of ovary. New Engl J Med 1985; 312: 474-83.
6. Le Cesne A. Chimiothérapie des sarcomes des tissus mous métastatiques. Press Med 1995; 24: 1214-20.
7. Bouché O, Bosset JF, Rougier Ph, et al. Le LV5FUU2 est supérieur au classique FUFOLld dans les cancers colorectaux métastatiques: résultats d'une étude de phase III multicentrique. Gastroenterol Clin Biol 1996; 20: A6.
8. Rougier Ph, Toma C, Fabri MC, Ducreux M. Chimiothérapie des tumeurs neuroendocrines digestives. Ann Gastroenterol Hepatol 1995; 31: 117-20.
9. Rougier Ph, Wils J, Wilke H, et al. Cancers gastriques avancés. Essai de phase II multicentrique comparant trois protocoles de chimiothérapie. Gastroenterol 19963; 20: A31.
10. Sugarbaker PH, Cunliffe W, Belliveau JF, de Bruin E, Graves T. Rationale for perioperative intraperitoneal chemotherapy as surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treat 1988; 1: 66-79.
11. Jacquet P. Elias D, Sugarbaker PH. L'implantation tumorale dans les sites de cicatrisation après chirurgie des cancers digestifs. J Chir (Paris) 1996; 133: 175-82.
12. Sugarbaker PH, Cunlifle WJ, Belliveau J, et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989; 16: 83-97.
13. Elias D. Répercussion de l'acte chirurgical sur la croissance des tumeurs. Ann Chir 1990; 44: 699-704.
14. Elias D. La chimiotherapie intra-péritonéale immédiate après chirurgie de réduction dans les carcinoses péritonéales: pourquoi? Pour qui? Ann Chir 1995; 130: 387-93.
15. Hansen E, Wolff N, Knuechel R, Rushoff J, Hofsaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg 1995; 130: 387-93.
16. Sugarbaker PH, Jabonski K.A. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221: 124-32.
17. Yonemura Y, Fujimura T, Nishimura G, et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996; 119: 437-44.
18. Yu W, Sugarbaker PH, Whang I. Randomized controlled trial of early postoperative intraperitoneal chemotherapy in gastric cancer: a preliminary report. Reg Cancer Treat 1994; 2: 90-3.
19. Murakami A, Koga S, Maeta M. Thermochemosensitivity: augmentation by hyperthermia of cytotoxicity of anticancer drugs against human colorectal cancer, measured by the human tumor clonogenic assay. Oncology 1988; 45: 236-41.
20. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res 1979; 39: 2264-9.
21. Elias D, Damia E, Puizillout JM, et al. Thermic homogeneity and standardization of intra-peritoneal chemohyperthermia for peritoneal carcinomatosis. Reg Cancer Treat 1997 (in press).
22. Elias D, Detroz B, Debane E, et al. Treatment of peritoneal carcinomatosis by intraperitoneal chemohyperthermia: reliable and unreliable concepts. Hepatogastroenterology 1994; 41: 207-13.
23. Elias D, Damia E, Debane B, et al. Chimio-hyperthermie intra-péritonéale peropératoire pour carcinose: une technologie difficile à mettre au point. Gasroenterol Clin Biol 1995; 19: A201.